MORIGI, ALICE
 Distribuzione geografica
Continente #
EU - Europa 2.279
NA - Nord America 1.266
AS - Asia 1.232
AF - Africa 85
SA - Sud America 60
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.927
Nazione #
US - Stati Uniti d'America 1.244
NL - Olanda 729
DE - Germania 524
IT - Italia 432
SG - Singapore 368
VN - Vietnam 312
CN - Cina 286
SE - Svezia 187
HK - Hong Kong 118
GB - Regno Unito 110
RU - Federazione Russa 69
IN - India 52
FR - Francia 48
BR - Brasile 44
IE - Irlanda 40
UA - Ucraina 35
TG - Togo 28
FI - Finlandia 26
JO - Giordania 24
KR - Corea 23
CI - Costa d'Avorio 22
NG - Nigeria 16
CA - Canada 15
BE - Belgio 13
AR - Argentina 12
ID - Indonesia 12
ZA - Sudafrica 12
ES - Italia 11
JP - Giappone 11
PL - Polonia 11
AT - Austria 10
TR - Turchia 9
BG - Bulgaria 6
EE - Estonia 6
MX - Messico 6
SC - Seychelles 6
AU - Australia 4
RO - Romania 4
RS - Serbia 4
DK - Danimarca 3
LT - Lituania 3
EC - Ecuador 2
IQ - Iraq 2
IR - Iran 2
MK - Macedonia 2
MY - Malesia 2
PT - Portogallo 2
QA - Qatar 2
SA - Arabia Saudita 2
BD - Bangladesh 1
CH - Svizzera 1
CL - Cile 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
EU - Europa 1
IL - Israele 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MN - Mongolia 1
NO - Norvegia 1
OM - Oman 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
Totale 4.927
Città #
Kerkrade 666
Frankfurt am Main 352
Singapore 263
Ashburn 184
Chandler 141
Hong Kong 116
Santa Clara 115
Fairfield 95
Dong Ket 93
Southend 87
Bologna 66
Milan 52
Hefei 45
Beijing 44
Ho Chi Minh City 44
Princeton 44
Rome 42
Houston 41
Dublin 40
Seattle 37
Boardman 34
Los Angeles 31
Falkenstein 30
Kyiv 30
Berlin 29
Lomé 28
Hanoi 27
Wilmington 27
Woodbridge 26
Amman 24
Cambridge 23
New York 23
Seoul 23
Abidjan 22
Ann Arbor 22
Helsinki 20
Bremen 16
Abeokuta 15
Redmond 13
Secaucus 13
Brussels 12
Düsseldorf 11
Turin 11
Buffalo 10
Catania 10
Nanjing 10
Westminster 10
Columbus 9
Jinan 9
Shenyang 9
Tokyo 9
Warsaw 9
Da Nang 8
Jakarta 8
Olalla 8
São Paulo 8
Toronto 8
Chicago 7
Dallas 7
Des Moines 7
Guangzhou 7
Istanbul 7
Nuremberg 7
San Diego 7
Zhengzhou 7
Bengaluru 6
Florence 6
Lappeenranta 6
Modena 6
Verona 6
Vienna 6
Haiphong 5
Hyderabad 5
Jiaxing 5
London 5
Orem 5
Ottawa 5
Padova 5
Parma 5
Redwood City 5
Reggio Emilia 5
Saint Petersburg 5
Belgrade 4
Brooklyn 4
Changsha 4
Cinisello Balsamo 4
Ha Long 4
Murmansk 4
Nova Milanese 4
Nuoro 4
Quận Một 4
Redondo Beach 4
Stockholm 4
Thái Nguyên 4
Yubileyny 4
Adelaide 3
Atlanta 3
Aversa 3
Bergamo 3
Bắc Giang 3
Totale 3.416
Nome #
90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years 1.449
BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma: a real-life experience 380
Design of New Personalized Therapeutic Approaches for Diffuse Large B-Cell Lymphoma through Gut Microbiome Profiling 205
The Berlin-Frankfurt-Münster protocol for the upfront treatment of aggressive lymphomas: The Bologna experience 202
(90) Y-ibritumomab tiuxetan in patients with extra-nodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) - The Zeno Study 190
Long-term responders after Brentuximab vedotin: Single-center experience on relapsed and refractory hodgkin lymphoma and anaplastic large cell lymphoma patients 179
Bendamustine-rituximab regimen in untreated indolent marginal zone lymphoma: experience on 65 patients 172
The treatment of primary mediastinal large B-cell lymphoma: A two decades monocentric experience with 98 patients 166
PD-1 blockade as bridge to allogenic stem cell transplantation in relapsed/refractory Hodgkin lymphoma patients: a retrospective single center case series 163
BRAF V600E-positive monomorphic epitheliotropic intestinal T-cell lymphoma complicating the course of hairy cell leukemia 152
A case report of the long treatment experience of a Sézary syndrome responder patient: 16 years through all the systemic and innovative therapies 152
Effectiveness of chemotherapy after anti-PD-1 blockade failure for relapsed and refractory Hodgkin lymphoma 145
Italian real life experience with ibrutinib: results of a large observational study on 77 relapsed/refractory mantle cell lymphoma 144
Treatment and outcomes of primary mediastinal B cell lymphoma: a three-decade monocentric experience with 151 patients 134
Granulomatous tattoo reaction in a nivolumab-treated patient 130
Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia 128
Efficacy and Safety of Frontline Single‐Agent Rituximab in Extranodal Marginal Zone Lymphoma 125
Potential survival benefit for patients receiving autologous hematopoietic stem cell transplantation after checkpoint inhibitors for relapsed/refractory Hodgkin lymphoma: A real-life experience 117
The treatment of hairy cell leukemia with a focus on long lasting responses to cladribine: A 30-year experience 108
Successful stem cell harvest and autologous transplantation in a patient with cold agglutinin syndrome and aggressive lymphoma 101
Prolonged responses to brentuximab vedotin as last therapy in Hodgkin lymphoma failing autologous transplantation: A case series 98
Long-term efficacy and safety of ibrutinib in the treatment of CLL patients: A real life experience 93
Spontaneous remission of follicular lymphoma 90
Intravascular Large B-cell Lymphoma Successfully Treated with Autologous Transplantation 72
Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia 70
Endobronchial Presentation of Hodgkin Lymphoma Responding to Pembrolizumab: A Case Report 59
Totale 5.024
Categoria #
all - tutte 12.642
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.642


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021240 0 0 0 0 0 6 5 15 40 9 16 149
2021/2022480 81 11 16 43 30 18 3 36 13 57 106 66
2022/2023645 46 100 49 85 54 43 14 61 99 16 40 38
2023/2024277 19 40 27 35 27 29 12 19 9 26 10 24
2024/20251.126 69 104 83 74 169 80 104 54 27 108 52 202
2025/20261.868 159 194 114 131 163 1.107 0 0 0 0 0 0
Totale 5.024